Mark Strobeck
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark Strobeck
Windtree Therapeutics Inc /De/ reported in an 8-K filed August 14, 2024 that Mark Strobeck was appointed lead independent director, effective August 13, 2024.
“On August 13, 2024, the Board appointed Mark Strobeck, Ph.D., to serve as lead independent director, effective August 13, 2024, until his successor is duly qualified and elected or until his earlier death, resignation, or removal, or until otherwise determined by the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Windtree Therapeutics Inc /De/
Other people whose current roles at this company are on record from its filings.
- Jed Latkin CEO, Board Member
- Craig E. Fraser Chairman, Board Member
- Former Senior VP CFO
- Jamie McAndrew CFO, Chief Accounting Officer
- John Tattory CFO
- Senior VP CFO
- Diane Carman General Counsel
- Andrew Kucharchuk Board Member
- Daniel Geffken Board Member
- Dr. Evan Loh Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.